Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels.
Ultrasound and fluoroscopic imaging techniques were used to monitor the gastric retention of enzyme-digestible hydrogels in the canine stomach. When water was present in the stomach, ultrasound imaging was very effective in monitoring the position of the hydrogel in the stomach, solvent penetration into the gel, and the gastric tissue-gel interactions during peristalsis. Rubbery or fully swollen hydrogels appeared as sonolucent objects with ultrasound imaging. Partially swollen hydrogels displayed a sonolucent outer layer due to solvent penetration and a centrally located bright echo resulting from the acoustic impedance mismatch at the glassy/rubbery interface. The degree of gastric tissue-gel interactions during peristalsis was inversely related to the extent of lumenal distention with water. The effectiveness of peristaltic contractions in driving the hydrogel toward the pyloric sphincter increased as the water was emptied from the stomach. In the absence of water, imaging of the gel with ultrasound became difficult. For this reason, gels were loaded with diatrizoate meglumine/sodium diatrizoate to visualize in real-time using fluoroscopic imaging. Fluoroscopic imaging allowed only indirect assessment of the hydrogel movement during peristalsis and the degree of hydrogel swelling. The gastric retention of the hydrogel under fasted conditions was influenced by the degree of gel deformation in response to peristaltic contractions. Hydrogels with a low degree of deformation during peristalsis showed long gastric retention times. The utilization of ultrasound imaging and fluoroscopic imaging for monitoring dynamic events in the stomach provided information on hydrogel properties which are important to gastric retention. The use of these imaging techniques in the development of long-term oral drug delivery systems is described.
Shalaby
W S
WS
Purdue University, School of Pharmacy, School of Veterinary Medicine, West Lafayette, Indiana 47907.
Blevins
W E
WE
Park
K
K
D000284:Administration, Oral; D000818:Animals; D001672:Biocompatible Materials / Q000493:pharmacokinetics*; D004285:Dogs; D016503:Drug Delivery Systems; D005753:Gastric Mucosa / Q000378:metabolism*; D005782:Gels; D008422:Materials Testing; D011205:Povidone / Q000493:pharmacokinetics*; D011859:Radiography; D012709:Serum Albumin / Q000493:pharmacokinetics; D013270:Stomach / Q000000981:diagnostic imaging; D014463:Ultrasonography
D001672:Biocompatible Materials; D005782:Gels; D012709:Serum Albumin; D011205:Povidone